烟酰胺单核苷酸的功能及其抗衰老作用的研究进展

王敏; 曹媛; 李云; 王陆; 刘育妍; 邓子辉; 朱连荣; 康红军

doi:10.1631/jzus.B2300886

Your Location：

Home >

Browse articles >

烟酰胺单核苷酸的功能及其抗衰老作用的研究进展

Scan QR Code

文章被引用时，请邮件提醒。

Submit

Review | Updated：2024-09-20

烟酰胺单核苷酸的功能及其抗衰老作用的研究进展
Research advances in the function and anti-aging effects of nicotinamide mononucleotide
浙江大学学报（英文版）（B辑：生物医学和生物技术） 2024年25卷第9期页码：723-735
Affiliations：

1.Chinese PLA Medical School, Beijing 100853, China
2.Department of Critical Care Medicine, the First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China
3.Department of Emergency, the Second Hospital of Hebei Medical University, Shijiazhuang 050004, China
4.Department of Biochemistry, Chinese PLA Medical School, Beijing 100853, China
5.Department of Clinical Nutrition, the First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China
6.Nephrology Institute of the Chinese People’s Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Department of Nephrology, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China
Funds：
DOI：10.1631/jzus.B2300886
中图分类号：
CSTR：
纸质出版日期： 2024-09-15 ，

收稿日期： 2023-12-07 ，

修回日期： 2024-03-10 ，
Accepted：

王敏,曹媛,李云等.烟酰胺单核苷酸的功能及其抗衰老作用的研究进展[J].浙江大学学报（英文版）（B辑：生物医学和生物技术）,2024,25(09):723-735.

Min WANG, Yuan CAO, Yun LI, et al. Research advances in the function and anti-aging effects of nicotinamide mononucleotide[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2024,25(9):723-735.
王敏,曹媛,李云等.烟酰胺单核苷酸的功能及其抗衰老作用的研究进展[J].浙江大学学报（英文版）（B辑：生物医学和生物技术）,2024,25(09):723-735. DOI： 10.1631/jzus.B2300886.

Min WANG, Yuan CAO, Yun LI, et al. Research advances in the function and anti-aging effects of nicotinamide mononucleotide[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2024,25(9):723-735. DOI： 10.1631/jzus.B2300886.

摘要

老龄化和年龄相关疾病已成为全球当代社会面临的重大挑战和沉重负担。解决这些问题是一项势在必行的任务，其目的是延缓衰老过程，并找到与年龄有关的退行性疾病的有效治疗方法。最近的研究强调了烟酰胺腺嘌呤二核苷酸（NAD

）在抗衰老领域的重要作用。经验证明，补充烟酰胺单核苷酸（NMN）可以提高体内NAD

水平，从而改善某些与年龄相关的退行性疾病。NMN的抗衰老机制主要在于其对细胞能量代谢的影响、对细胞凋亡的抑制、对免疫功能的调节和对基因组稳定性的保持，这些共同延缓了衰老进程。本文对NMN抗衰老机制的现有研究进行了批判性的回顾和评价，阐明了当前研究的内在局限性，并提出了抗衰老研究的新途径。

Abstract

Aging and age-related ailments have emerged as critical challenges and great burdens within the global contemporary society. Addressing these concerns is an imperative task

with the aims of postponing the aging process and finding effective treatments for age-related degenerative diseases. Recent investigations have highlighted the significant roles of nicotinamide adenine dinucleotide (NAD

) in the realm of anti-aging. It has been empirically evidenced that supplementation with nicotinamide mononucleotide (NMN) can elevate NAD

levels in the body

thereby ameliorating certain age-related degenerative diseases. The p

rincipal anti-aging mechanisms of NMN essentially lie in its impact on cellular energy metabolism

inhibition of cell apoptosis

modulation of immune function

and preservation of genomic stability

which collectively contribute to the deferral of the aging process. This paper critically reviews and evaluates existing research on the anti-aging mechanisms of NMN

elucidates the inherent limitations of current research

and proposes novel avenues for anti-aging investigations.

关键词

烟酰胺单核苷酸（NMN）抗衰老能量代谢细胞凋亡DNA修复

Keywords

Nicotinamide mononucleotide (NMN)Anti-agingEnergy metabolismApoptosisDNA repair

references

Abdellatif M, Sedej S, Kroemer G, 2021. NAD+ metabolism in cardiac health, aging, and disease. Circulation, 144(22):1795-1817. https://doi.org/10.1161/CIRCULATIONAHA.121.056589https://doi.org/10.1161/CIRCULATIONAHA.121.056589

Aflatounian A, Paris VR, Richani D, et al., 2022. Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: possible role in metabolic dysregulation. Mol Metab, 65:101583. https://doi.org/10.1016/j.molmet.2022.101583https://doi.org/10.1016/j.molmet.2022.101583

Amjad S, Nisar S, Bhat AA, et al., 2021. Role of NAD+ in regulating cellular and metabolic signaling pathways. Mol Metab, 49:101195. https://doi.org/10.1016/j.molmet.2021.101195https://doi.org/10.1016/j.molmet.2021.101195

Bai P, Canto C, Brunyánszki A, et al., 2011a. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab, 13(4):450-460. https://doi.org/10.1016/j.cmet.2011.03.013https://doi.org/10.1016/j.cmet.2011.03.013

Bai P, Canto C, Oudart H, et al., 2011b. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab, 13(4):461-468. https://doi.org/10.1016/j.cmet.2011.03.004https://doi.org/10.1016/j.cmet.2011.03.004

Belenky P, Bogan KL, Brenner C, 2007. NAD+ metabolism in health and disease. Trends Biochem Sci, 32(1):12-19. https://doi.org/10.1016/j.tibs.2006.11.006https://doi.org/10.1016/j.tibs.2006.11.006

Bertoldo MJ, Listijono DR, Ho WHJ, et al., 2020. NAD+ repletion rescues female fertility during reproductive aging. Cell Rep, 30(6):1670-1681.e7. https://doi.org/10.1016/j.celrep.2020.01.058https://doi.org/10.1016/j.celrep.2020.01.058

Brito S, Baek JM, Cha B, et al., 2022. Nicotinamide mononucleotide reduces melanin production in aged melanocytes by inhibiting cAMP/Wnt signaling. J Dermatol Sci, 106(3):159-169. https://doi.org/10.1016/j.jdermsci.2022.05.002https://doi.org/10.1016/j.jdermsci.2022.05.002

Camacho-Pereira J, Tarrago MG, Chini CCS, et al., 2016. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab, 23(6):1127-1139. https://doi.org/10.1016/j.cmet.2016.05.006https://doi.org/10.1016/j.cmet.2016.05.006

Chalkiadaki A, Guarente L, 2015. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer, 15(10):608-624. https://doi.org/10.1038/nrc3985https://doi.org/10.1038/nrc3985

Chen XH, Amorim JA, Moustafa GA, et al., 2020. Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment. Aging, 12(24):24504-24521. https://doi.org/10.18632/aging.202453https://doi.org/10.18632/aging.202453

Chini CCS, Peclat TR, Warner GM, et al., 2020. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels. Nat Metab, 2(11):1284-1304. https://doi.org/10.1038/s42255-020-00298-zhttps://doi.org/10.1038/s42255-020-00298-z

Cohen MS, 2020. Interplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family. Genes Dev, 34(5-6):254-262. https://doi.org/10.1101/gad.335109.119https://doi.org/10.1101/gad.335109.119

Covarrubias AJ, Perrone R, Grozio A, et al., 2021. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol, 22(2):119-141. https://doi.org/10.1038/s41580-020-00313-xhttps://doi.org/10.1038/s41580-020-00313-x

Cros C, Margier M, Cannelle H, et al., 2022. Nicotinamide mononucleotide administration triggers macrophages reprogramming and alleviates inflammation during sepsis induced by experimental peritonitis. Front Mol Biosci, 9:895028. https://doi.org/10.3389/fmolb.2022.895028https://doi.org/10.3389/fmolb.2022.895028

de Vos M, Schreiber V, Dantzer F, 2012. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem Pharmacol, 84(2):137-146. https://doi.org/10.1016/j.bcp.2012.03.018https://doi.org/10.1016/j.bcp.2012.03.018

di Stefano M, Nascimento-Ferreira I, Orsomando G, et al., 2015. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ, 22(5):731-742. https://doi.org/10.1038/cdd.2014.164https://doi.org/10.1038/cdd.2014.164

Fang EF, Scheibye-Knudsen M, Brace LE, et al., 2014. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD+/SIRT1 reduction. Cell, 157(4):882-896. https://doi.org/10.1016/j.cell.2014.03.026https://doi.org/10.1016/j.cell.2014.03.026

Fang EF, Kassahun H, Croteau DL, et al., 2016. NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab, 24(4):566-581. https://doi.org/10.1016/j.cmet.2016.09.004https://doi.org/10.1016/j.cmet.2016.09.004

Fletcher RS, Ratajczak J, Doig CL, et al., 2017. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Mol Metab, 6(8):819-832. https://doi.org/10.1016/j.molmet.2017.05.011https://doi.org/10.1016/j.molmet.2017.05.011

Frederick DW, Loro E, Liu L, et al., 2016. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metab, 24(2):269-282. https://doi.org/10.1016/j.cmet.2016.07.005https://doi.org/10.1016/j.cmet.2016.07.005

Garten A, Grohmann T, Kluckova K, et al., 2019. Sorafenib-induced apoptosis in hepatocellular carcinoma is reversed by SIRT1. Int J Mol Sci, 20(16):4048. https://doi.org/10.3390/ijms20164048https://doi.org/10.3390/ijms20164048

Hou YJ, Lautrup S, Cordonnier S, et al., 2018. NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new ad mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci USA, 115(8):E1876-E1885. https://doi.org/10.1073/pnas.1718819115https://doi.org/10.1073/pnas.1718819115

Hsu CP, Oka S, Shao D, et al., 2009. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res, 105(5):481-491. https://doi.org/10.1161/circresaha.109.203703https://doi.org/10.1161/circresaha.109.203703

Huang P, Zhou Y, Tang WH, et al., 2022. Long-term treatment of Nicotinamide mononucleotide improved age-related diminished ovary reserve through enhancing the mitophagy level of granulosa cells in mice. J Nutr Biochem, 101:108911. https://doi.org/10.1016/j.jnutbio.2021.108911https://doi.org/10.1016/j.jnutbio.2021.108911

Imai SI, 2011. Dissecting systemic control of metabolism and aging in the NAD world: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett, 585(11):1657-1662. https://doi.org/10.1016/j.febslet.2011.04.060https://doi.org/10.1016/j.febslet.2011.04.060

Irie J, Inagaki E, Fujita M, et al., 2020. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J, 67(2):153-160. https://doi.org/10.1507/endocrj.EJ19-0313https://doi.org/10.1507/endocrj.EJ19-0313

Jiang Y, Wang D, Zhang C, et al., 2023. Nicotinamide mononucleotide restores oxidative stress-related apoptosis of oocyte exposed to benzyl butyl phthalate in mice. Cell Prolif, 56(8):e13419. https://doi.org/10.1111/cpr.13419https://doi.org/10.1111/cpr.13419

Jiang YF, Liu TT, Lee CH, et al., 2020. The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1. Nature, 588(7839):658-663. https://doi.org/10.1038/s41586-020-2862-zhttps://doi.org/10.1038/s41586-020-2862-z

Kane AE, Sinclair DA, 2018. Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases. Circ Res, 123(7):868-885. https://doi.org/10.1161/circresaha.118.312498https://doi.org/10.1161/circresaha.118.312498

Li L, Han Q, Chen Y, et al., 2023. β-nicotinamide mononucleotide rescues the quality of aged oocyte and improves subsequent embryo development in pigs. PLoS ONE, 18(10):e0291640. https://doi.org/10.1371/journal.pone.0291640https://doi.org/10.1371/journal.pone.0291640

Luo CT, Ding WX, Yang CM, et al., 2022. Nicotinamide mononucleotide administration restores redox homeostasis via the Sirt3‒Nrf2 axis and protects aged mice from oxidative stress-induced liver injury. J Proteome Res, 21(7):1759-1770. https://doi.org/10.1021/acs.jproteome.2c00167https://doi.org/10.1021/acs.jproteome.2c00167

Margier M, Kuehnemann C, Hulo N, et al., 2023. Nicotinamide mononucleotide administration prevents doxorubicin-induced cardiotoxicity and loss in physical activity in mice. Cells, 12(1):108. https://doi.org/10.3390/cells12010108https://doi.org/10.3390/cells12010108

Meng F, Zhang YN, Du JY, et al., 2024. Nicotinamide mononucleotide maintains cytoskeletal stability and fortifies mitochondrial function to mitigate oocyte damage induced by triocresyl phosphate. Ecotoxicol Environ Saf, 275:116264. https://doi.org/10.1016/j.ecoenv.2024.116264https://doi.org/10.1016/j.ecoenv.2024.116264

Miao YL, Cui ZK, Gao Q, et al., 2020. Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes. Cell Rep, 32(5):107987. https://doi.org/10.1016/j.celrep.2020.107987https://doi.org/10.1016/j.celrep.2020.107987

Mills KF, Yoshida S, Stein LR, et al., 2016. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab, 24(6):795-806. https://doi.org/10.1016/j.cmet.2016.09.013https://doi.org/10.1016/j.cmet.2016.09.013

Monzel AS, Enríquez JA, Picard M, 2023. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab, 5(4):546-562. https://doi.org/10.1038/s42255-023-00783-1https://doi.org/10.1038/s42255-023-00783-1

Nomiyama T, Setoyama D, Yasukawa T, et al., 2022. Mitochondria metabolomics reveals a role of β-nicotinamide mononucleotide metabolism in mitochondrial DNA replication. J Biochem, 171(3):325-338. https://doi.org/10.1093/jb/mvab136https://doi.org/10.1093/jb/mvab136

Okabe K, Yaku K, Tobe K, et al., 2019. Implications of altered NAD metabolism in metabolic disorders. J Biomed Sci, 26:34. https://doi.org/10.1186/s12929-019-0527-8https://doi.org/10.1186/s12929-019-0527-8

Palmer AK, Jensen MD, 2022. Metabolic changes in aging humans: current evidence and therapeutic strategies. J Clin Invest, 132(16):e158451. https://doi.org/10.1172/jci158451https://doi.org/10.1172/jci158451

Piedra-Quintero ZL, Wilson Z, Nava P, et al., 2020. CD38: an immunomodulatory molecule in inflammation and autoimmunity. Front Immunol, 11:597959. https://doi.org/10.3389/fimmu.2020.597959https://doi.org/10.3389/fimmu.2020.597959

Poddar SK, Sifat AE, Haque S, et al., 2019. Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule. Biomolecules, 9:34. https://doi.org/10.3390/biom9010034https://doi.org/10.3390/biom9010034

Pu Q, Guo XX, Hu JJ, et al., 2022. Nicotinamide mononucleotide increases cell viability and restores tight junctions in high-glucose-treated human corneal epithelial cells via the SIRT1/Nrf2/HO-1 pathway. Biomed Pharmacother, 147:112659. https://doi.org/10.1016/j.biopha.2022.112659https://doi.org/10.1016/j.biopha.2022.112659

Revollo JR, Körner A, Mills KF, et al., 2007. Nampt/PBEF/visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metab, 6(5):363-375. https://doi.org/10.1016/j.cmet.2007.09.003https://doi.org/10.1016/j.cmet.2007.09.003

Sanada S, Komuro I, Kitakaze M, 2011. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol, 301(5):H1723-H1741. https://doi.org/10.1152/ajpheart.00553.2011https://doi.org/10.1152/ajpheart.00553.2011

Shen Q, Zhang SJ, Xue YZ, et al., 2021. Biological synthesis of nicotinamide mononucleotide. Biotechnol Lett, 43(12):2199-2208. https://doi.org/10.1007/s10529-021-03191-1https://doi.org/10.1007/s10529-021-03191-1

Singh AK, Mohanty A, Kumar SL, et al., 2024. Diminished NAD+ levels and activation of retrotransposons promote postovulatory aged oocyte (POAO) death. Cell Death Discov, 10:104. https://doi.org/10.1038/s41420-024-01876-whttps://doi.org/10.1038/s41420-024-01876-w

Surjana D, Halliday GM, Martin AJ, et al., 2012. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol, 132(5):1497-1500. https://doi.org/10.1038/jid.2011.459https://doi.org/10.1038/jid.2011.459

Surjana D, Halliday GM, Damian DL, 2013. Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin. Carcinogenesis, 34(5):1144-1149. https://doi.org/10.1093/carcin/bgt017https://doi.org/10.1093/carcin/bgt017

Takeda K, Okumura K, 2021. Nicotinamide mononucleotide augments the cytotoxic activity of natural killer cells in young and elderly mice. Biomed Res, 42(5):173-179. https://doi.org/10.2220/biomedres.42.173https://doi.org/10.2220/biomedres.42.173

Thompson BC, Surjana D, Halliday GM, et al., 2014. Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in primary melanocytes. Exp Dermatol, 23(7):509-511. https://doi.org/10.1111/exd.12430https://doi.org/10.1111/exd.12430

Tong D, Schiattarella GG, Jiang N, et al., 2021. NAD+ repletion reverses heart failure with preserved ejection fraction. Circ Res, 128(11):1629-1641. https://doi.org/10.1161/CIRCRESAHA.120.317046https://doi.org/10.1161/CIRCRESAHA.120.317046

Verma K, Jaiswal R, Paliwal S, et al., 2023. An insight into PI3K/Akt pathway and associated protein‒protein interactions in metabolic syndrome: a recent update. J Cell Biochem, 124(7):923-942. https://doi.org/10.1002/jcb.30433https://doi.org/10.1002/jcb.30433

Walker MA, Tian R, 2018. Raising NAD in heart failure: time to translate? Circulation, 137(21):2274-2277. https://doi.org/10.1161/CIRCULATIONAHA.117.032626https://doi.org/10.1161/CIRCULATIONAHA.117.032626

Walker MA, Chen H, Yadav A, et al., 2023. Raising NAD+ level stimulates short-chain dehydrogenase/reductase proteins to alleviate heart failure independent of mitochondrial protein deacetylation. Circulation, 148(25):2038-2057. https://doi.org/10.1161/CIRCULATIONAHA.123.066039https://doi.org/10.1161/CIRCULATIONAHA.123.066039

Wang H, Sun YA, Pi CC, et al., 2022. Nicotinamide mononucleotide supplementation improves mitochondrial dysfunction and rescues cellular senescence by NAD+/Sirt3 pathway in mesenchymal stem cells. Int J Mol Sci, 23(23):14739. https://doi.org/10.3390/ijms232314739https://doi.org/10.3390/ijms232314739

Wang LQ, Zhao MY, Qian R, et al., 2023. Nicotinamide mononucleotide ameliorates silica-induced lung injury through the Nrf2-regulated glutathione metabolism pathway in mice. Nutrients, 15(1):143. https://doi.org/10.3390/nu15010143https://doi.org/10.3390/nu15010143

Wang QH, Li Y, Dou DY, et al., 2021. Nicotinamide mononucleotide-elicited NAMPT signaling activation aggravated adjuvant-induced arthritis in rats by affecting peripheral immune cells differentiation. Int Immunopharmacol, 98:107856. https://doi.org/10.1016/j.intimp.2021.107856https://doi.org/10.1016/j.intimp.2021.107856

Wątroba M, Dudek I, Skoda M, et al., 2017. Sirtuins, epigenetics and longevity. Ageing Res Rev, 40:11-19. https://doi.org/10.1016/j.arr.2017.08.001https://doi.org/10.1016/j.arr.2017.08.001

Yoo KH, Tang JJ, Rashid MA, et al., 2021. Nicotinamide mononucleotide prevents cisplatin-induced cognitive impairments. Cancer Res, 81(13):3727-3737. https://doi.org/10.1158/0008-5472.CAN-20-3290https://doi.org/10.1158/0008-5472.CAN-20-3290

Yoshino J, Mills KF, Yoon MJ, et al., 2011. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab, 14(4):528-536. https://doi.org/10.1016/j.cmet.2011.08.014https://doi.org/10.1016/j.cmet.2011.08.014

Yoshino M, Yoshino J, Kayser BD, et al., 2021. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547):1224-1229. https://doi.org/10.1126/science.abe9985https://doi.org/10.1126/science.abe9985

Yu P, Ma SC, Dai XC, et al., 2020. Inhibitive effect of nicotinamide mononucleotide on angiotensin II-induced cardiac fibrosis in mice and its mechanism. Chin J Mult Organ Dis Elderly, 19(6):452-456 (in Chinese). https://doi.org/10.11915/j.issn.1671-5403.2020.06.106https://doi.org/10.11915/j.issn.1671-5403.2020.06.106

Zhang GZ, Deng YJ, Xie QQ, et al., 2020. Sirtuins and intervertebral disc degeneration: roles in inflammation, oxidative stress, and mitochondrial function. Clin Chim Acta, 508:33-42. https://doi.org/10.1016/j.cca.2020.04.016https://doi.org/10.1016/j.cca.2020.04.016

Zhang RL, Shen YY, Zhou L, et al., 2017. Short-term administration of nicotinamide mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure. J Mol Cell Cardiol, 112:64-73. https://doi.org/10.1016/j.yjmcc.2017.09.001https://doi.org/10.1016/j.yjmcc.2017.09.001

Zhao C, Li WJ, Duan HY, et al., 2020. NAD+ precursors protect corneal endothelial cells from UVB-induced apoptosis. Am J Physiol Cell Physiol, 318(4):C796-C805. https://doi.org/10.1152/ajpcell.00445.2019https://doi.org/10.1152/ajpcell.00445.2019

Zhao YZ, Li H, Guo QL, et al., 2023. Multiple characteristic alterations and available therapeutic strategies of cellular senescence. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 24(2):101-114. https://doi.org/10.1631/jzus.B2200178https://doi.org/10.1631/jzus.B2200178

Zhou B, Wang DDH, Qiu YH, et al., 2020. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure. J Clin Invest, 130(11):6054-6063. https://doi.org/10.1172/JCI138538https://doi.org/10.1172/JCI138538

Zhou XR, Du HH, Ni LY, et al., 2021. Nicotinamide mononucleotide combined with lactobacillus fermentum TKSN041 reduces the photoaging damage in murine skin by activating AMPK signaling pathway. Front Pharmacol, 12:643089. https://doi.org/10.3389/fphar.2021.643089https://doi.org/10.3389/fphar.2021.643089

浏览量

Downloads

CSCD

工具集

关联资源

A proton birdcage coil integrated with interchangeable single loops for multi-nuclear MRI/MRS

Micropeptides: origins, identification, and potential role in metabolism-related diseases

Role of selenoprotein M knockdown in the melatonin antagonism of nickel-induced apoptosis and endoplasmic reticulum stress in mouse heart

AAZ2 induces mitochondrial-dependent apoptosis by targeting PDK1 in gastric cancer

Protective effect of recombinant Lactobacillus plantarum against H₂O₂-induced oxidative stress in HUVEC cells